Notice: This company has been marked as potentially delisted and may not be actively trading. Reneo Pharmaceuticals (RPHM) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Cormorant Asset Management's Strategic Acquisition of Reneo Pharmaceuticals SharesOctober 11, 2024 | finance.yahoo.comDeep Track Capital's Strategic Investment in Reneo PharmaceuticalsOctober 11, 2024 | finance.yahoo.comCarlyle Group Inc. Reduces Stake in Reneo Pharmaceuticals Inc.October 10, 2024 | finance.yahoo.comReneo Pharmaceuticals: Navigating Financial Challenges and Corporate ChangesOctober 9, 2024 | finance.yahoo.comOnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 MillionOctober 4, 2024 | globenewswire.comBaosheng Media Gr (NASDAQ:BAOS) Stock Quotes, Forecast and News SummaryOctober 3, 2024 | benzinga.comReneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKureOctober 2, 2024 | globenewswire.comNantahala Capital Management LLC Invests $846,000 in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)Nantahala Capital Management LLC purchased a new stake in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 547,804 shares of the company's stock, valOctober 1, 2024 | marketbeat.comBraden Michael Leonard Acquires 29,600 Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) StockSeptember 27, 2024 | insidertrades.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Purchases 29,600 SharesReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) major shareholder Braden Michael Leonard bought 29,600 shares of Reneo Pharmaceuticals stock in a transaction on Tuesday, September 24th. The stock was acquired at an average price of $1.41 per share, for a total transaction of $41,736.00. Following the purchase, the insider now owns 3,388,649 shares of the company's stock, valued at $4,777,995.09. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.September 26, 2024 | marketbeat.comBraden Michael Leonard Purchases 55,300 Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) StockSeptember 20, 2024 | insidertrades.comColor Star Tech (NASDAQ:ADD) Stock Quotes, Forecast and News SummarySeptember 12, 2024 | benzinga.comReneo Pharmaceuticals insider buys shares worth over $380kAugust 16, 2024 | investing.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Acquires 171,339 SharesAugust 15, 2024 | insidertrades.comRPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q2 2024August 13, 2024 | investorplace.comReneo Pharmaceuticals Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | globenewswire.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Receives Consensus Rating of "Reduce" from AnalystsReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) has been assigned a consensus recommendation of "Reduce" from the eight analysts that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and seven have assignJuly 28, 2024 | marketbeat.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Given Average Recommendation of "Reduce" by AnalystsShares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) have been given an average rating of "Reduce" by the eight ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating and seven have issued a hold rating on theJuly 3, 2024 | marketbeat.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHMJune 26, 2024 | globenewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHMJune 24, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAN, RPHM on Behalf of ShareholdersJune 21, 2024 | globenewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHMJune 21, 2024 | globenewswire.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Given Consensus Rating of "Reduce" by BrokeragesShares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) have been given an average recommendation of "Reduce" by the eight brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating and seven have given a hold rJune 8, 2024 | marketbeat.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Short Interest Up 18.2% in MayReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 3,630,000 shares, an increase of 18.2% from the April 30th total of 3,070,000 shares. Approximately 16.7% of the shares of the stock are sold short. Based on an average daily volume of 265,100 shares, the short-interest ratio is currently 13.7 days.June 2, 2024 | marketbeat.comHighbridge Capital Management LLC Purchases Shares of 1,121,704 Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)Highbridge Capital Management LLC acquired a new stake in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,121,704 shares of the company's stock, valued at aMay 30, 2024 | marketbeat.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Acquires 414,281 SharesMay 17, 2024 | insidertrades.comInsider Buying: Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Acquires 414,281 Shares of StockReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) major shareholder Braden Michael Leonard purchased 414,281 shares of the company's stock in a transaction that occurred on Tuesday, May 14th. The stock was bought at an average price of $1.54 per share, for a total transaction of $637,992.74. Following the transaction, the insider now directly owns 2,672,194 shares in the company, valued at $4,115,178.76. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Large shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC.May 16, 2024 | marketbeat.comMitchell Kapoor’s Hold Rating on Reneo Pharmaceuticals Amid OnKure Merger and Oncology Pipeline PotentialMay 14, 2024 | markets.businessinsider.comRENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHMMay 14, 2024 | businesswire.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Receives Average Rating of "Reduce" from BrokeragesReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) has been given an average rating of "Reduce" by the eight ratings firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and seven have assigned a hold rating to thMay 14, 2024 | marketbeat.comReneo Pharmaceuticals (NASDAQ:RPHM) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reiterated a "neutral" rating and issued a $1.50 price objective on shares of Reneo Pharmaceuticals in a report on Tuesday.May 14, 2024 | marketbeat.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Reneo Pharmaceuticals, Inc. - RPHMMay 13, 2024 | prnewswire.comReneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares RiseMay 13, 2024 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, RPHMMay 13, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Reneo Pharmaceuticals, Inc. has obtained a Fair Price in its Transaction with OnKureMay 13, 2024 | prnewswire.comRPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to ShareholdersMay 13, 2024 | businesswire.comReneo Pharmaceuticals, OnKure To MergeMay 13, 2024 | markets.businessinsider.comReneo Pharmaceuticals Sets Reverse Merger With OnKureMay 13, 2024 | marketwatch.comReneo Pharmaceuticals gains on deal to merge with OnKureMay 13, 2024 | msn.comReneo Pharmaceuticals and OnKure Announce Proposed MergerMay 13, 2024 | globenewswire.comMaintaining Hold on Reneo Pharmaceuticals Amidst Strategic Uncertainties and Pipeline SetbacksMay 10, 2024 | markets.businessinsider.comQ2 2024 EPS Estimates for Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Reduced by AnalystReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Free Report) - Analysts at Leerink Partnrs dropped their Q2 2024 EPS estimates for shares of Reneo Pharmaceuticals in a report issued on Tuesday, May 7th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will post earnings of ($0.22)May 10, 2024 | marketbeat.comReneo Pharmaceuticals, Inc.: Reneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 7, 2024 | finanznachrichten.deRPHM Stock Earnings: Reneo Pharmaceuticals Beats EPS for Q1 2024May 7, 2024 | investorplace.comReneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 7, 2024 | finance.yahoo.comReneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 7, 2024 | globenewswire.comBML Capital Management LLC Makes New Investment in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)BML Capital Management LLC bought a new position in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,314,229 shares of the company's stock, valued at approximatelyApril 24, 2024 | marketbeat.comReneo Pharmaceuticals Inc.April 14, 2024 | thestreet.comReneo Pharmaceuticals (NASDAQ:RPHM) Trading Up 0.6%Reneo Pharmaceuticals (NASDAQ:RPHM) Trading Up 0.6%April 3, 2024 | marketbeat.comSell Rating on Reneo Pharmaceuticals Amid Strategic Uncertainty and Reduced Price TargetMarch 31, 2024 | markets.businessinsider.com Get Reneo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter. Email Address “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in… >> YES! Send Me My FREE Gold Guide! RPHM Media Mentions By Week RPHM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPHM News Sentiment▼0.000.47▲Average Medical News Sentiment RPHM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPHM Articles This Week▼01▲RPHM Articles Average Week Get Reneo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACB News Today BNTC News Today FATE News Today NGNE News Today BMEA News Today ZNTL News Today SLN News Today STRO News Today MOLN News Today TCRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPHM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reneo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reneo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
